EHR Nudges to Improve Quality of Care in HF
Electronic Health Record Nudges to Improve Quality of Care in Heart Failure
1 other identifier
interventional
3
1 country
1
Brief Summary
The purpose of this pilot feasibility study is to test a pharmacist-facing clinical decision support tool designed to increase adherence to guideline-directed medical therapy and evaluate the tool using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) evaluation framework.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2023
CompletedFirst Posted
Study publicly available on registry
October 27, 2023
CompletedStudy Start
First participant enrolled
May 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2025
CompletedDecember 2, 2025
November 1, 2025
2 months
October 23, 2023
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reach
Percentage of alerts in which the pharmacist contacts the patient to discuss the low medication adherence rate
2-months
Secondary Outcomes (2)
Adoption
2-months
Implementation
After the end of the 2-month intervention period
Study Arms (1)
Active clinical decision support tool for pharmacists
OTHERIn this single arm, pilot feasibility study, pharmacists with be exposed to a clinical decision support tool to facilitate monitoring adherence to GDMT for patients with heart failure with reduced ejection fraction
Interventions
Clinical decision support tool to enable pharmacists to monitor adherence to guideline-directed medical therapy for patients with heart failure with reduced ejection fraction
Eligibility Criteria
You may qualify if:
- Pharmacist at Northwestern Medicine participating in the Medication Adjusted to Target (MAT) Clinic
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 23, 2023
First Posted
October 27, 2023
Study Start
May 13, 2025
Primary Completion
July 21, 2025
Study Completion
August 13, 2025
Last Updated
December 2, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Due to the small number of participants and the inability to fully de-identify the data, IPD will only be share with researchers with an appropriate data use agreement in place.